Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar i patients stratified by index manic or mixed episode

Journal of Affective Disorders

Volumn 147, Issue 1-3, 2013, Pages 365-372

  Yatham, Lakshmi N ^a   Fountoulakis, Konstantinos N ^b   Rahman, Zia ^c   Ammerman, Diane ^c   Fyans, Paula ^c   Marler, Sabrina V ^c   Baker, Ross A ^d   Carlson, Berit X ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c BRISTOL MYERS SQUIBB   (United States)

^d OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Aripiprazole; Bipolar disorder; Lithium; Treatment; Valproate

Indexed keywords

ARIPIPRAZOLE; LITHIUM; PLACEBO; VALPROIC ACID;

ADJUVANT THERAPY; ADULT; AGGRESSION; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MANIC PSYCHOSIS; MIXED MANIA AND DEPRESSION; MOTOR ACTIVITY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; SLEEP; SPEECH; THOUGHT DISORDER; TREMOR;

ADULT; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM COMPOUNDS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PIPERAZINES; QUINOLONES; RECURRENCE; SINGLE-BLIND METHOD; TRANQUILIZING AGENTS; VALPROIC ACID;

EID: 84875367915     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.11.042     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th revised edition 1994 American Psychiatric Press Washington, DC
2. Azorin, J.M;, Sapin, C;, Weiller, E. Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses. Journal of Affective Disorders 10.1016/j.jad.2012.07.013, in press
3. C.L. Bowden New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine Neuropsychopharmacology 19 1998 194 199
4. C.L. Bowden, E. Vieta, K.S. Ice, J.H. Schwartz, P.P. Wang, and M. Versavel Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial Journal of Clinical Psychiatry 71 2010 130 137
5. K.D. Burris, T.F. Molski, C. Xu, E. Ryan, K. Tottori, T. Kikuchi, F.D. Yocca, and P.B. Molinoff Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors Journal of Pharmacology and Experimental Therapeutics 302 2002 381 389
6. S. Dhillon Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder Drugs 72 2012 133 162
7. DSM-V, 2012. DSM-5 Development. Available online at: 〈http://www. dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=524〉. (accessed 23 05 12).
8. K.N. Fountoulakis, D. Kontis, X. Gonda, M. Siamouli, and L.N. Yatham Treatment of mixed bipolar states International Journal of Neuropsychopharmacology 27 2 2012 91 99
9. T.W. Freeman, J.L. Clothier, P. Pazzaglia, M.D. Lesem, and A.C. Swann A double-blind comparison of valproate and lithium in the treatment of acute mania American Journal of Psychiatry 149 1992 108 111
10. H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Moller, and S. Kasper The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania World Journal of Biological Psychiatry 10 2009 85 116
11. J.P. Houston, M. Tohen, E.K. Degenhardt, H.H. Jamal, L.L. Liu, and T.A. Ketter Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study Journal of Clinical Psychiatry 70 2009 1540 1547
12. S. Jordan, V. Koprivica, R. Chen, K. Tottori, T. Kikuchi, and C.A. Altar The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor European Journal of Pharmacology 441 2002 137 140
13. P.E. Keck, Jr;, J.R. Calabrese, R.S. Mcintyre, R.D. Mcquade, W.H. Carson, J.M. Eudicone, B.X. Carlson, R.N. Marcus, and R. Sanchez Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo Journal of Clinical Psychiatry 68 2007 1480 1491
14. P.E. Keck, and S.L. Mcelroy Bipolar disorder, obesity, and pharmacotherapy-associated weight gain Journal of Clinical Psychiatry 64 2003 1426 1435
15. T. Kikuchi, K. Tottori, Y. Uwahodo, T. Hirose, T. Miwa, Y. Oshiro, and S. Morita 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2((1H)) -qui nolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity Journal of Pharmacology and Experimental Therapeutics 274 1995 329 336
16. R. Marcus, A. Khan, L. Rollin, B. Morris, K. Timko, W. Carson, and R. Sanchez Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study Bipolar Disorders 13 2011 133 144
17. D.A. Shapiro, S. Renock, E. Arrington, L.A. Chiodo, L.X. Liu, D.R. Sibley, B.L. Roth, and R. Mailman Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 2003 1400 1411
18. A.D. Stark, S. Jordan, K.A. Allers, R.L. Bertekap, R. Chen, T. Mistry Kannan, T.F. Molski, F.D. Yocca, T. Sharp, T. Kikuchi, and K.D. Burris Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies Psychopharmacology 190 2007 373 382
19. T. Suppes, E.B. Dennehy, R.M. Hirschfeld, L.L. Altshuler, C.L. Bowden, J.R. Calabrese, M.L. Crismon, T.A. Ketter, G.S. Sachs, and A.C. Swann The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder Journal of Clinical Psychiatry 66 2005 870 886
20. T. Suppes, J. Eudicone, R. Mcquade, A. Pikalov, 3RD, and B. Carlson Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder Journal of Affective Disorders 107 2008 145 154
21. T. Suppes, E. Vieta, S. Liu, M. Brecher, and B. Paulsson Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127) American Journal of Psychiatry 166 2009 476 488
22. A.C. Swann, C.L. Bowden, D. Morris, J.R. Calabrese, F. Petty, J. Small, S.C. Dilsaver, and J.M. Davis Depression during mania. Treatment response to lithium or divalproex Archives of General Psychiatry 54 1997 37 42
23. A.C. Swann, C.L. Bowden, and D.D. Morris Classic mania: treatment response to divalproex or lithium (letter) Archives of General Psychiatry 55 1998 1050
24. Y. Tadori, R.A. Forbes, R.D. Mcquade, and T. Kikuchi In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors European Journal of Pharmacology 668 2011 355 365
25. M. Tohen, K.N. Chengappa, T. Suppes, R.W. Baker, C.A. Zarate, C.L. Bowden, G.S. Sachs, D.J. Kupfer, S.N. Ghaemi, P.D. Feldman, R.C. Risser, A.R. Evans, and J.R. Calabrese Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser V mood stabiliser alone British Journal of Psychiatry 184 2004 337 345
26. C. Torrent, B. Amann, J. Sanchez-Moreno, F. Colom, M. Reinares, M. Comes, A.R. Rosa, J. Scott, and E. Vieta Weight gain in bipolar disorder: pharmacological treatment as a contributing factor Acta Psychiatrica Scandinavica 118 2008 4 18
27. E. Vieta, and C. Morralla Prevalence of mixed mania using 3 definitions Journal of Affective Disorders 125 2010 61 73
28. E. Vieta, T. Suppes, I. Eggens, I. Persson, B. Paulsson, and M. Brecher Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126) Journal of Affective Disorders 109 2008 251 263
29. E. Vieta, C. T'joen, R.D. Mcquade, W.H. Carson, Jr;, R.N. Marcus, R. Sanchez, R. Owen, and L. Nameche Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study American Journal of Psychiatry 165 2008 1316 1325
30. S.W. Woods, R. Money, and C.B. Baker Does the manic/mixed episode distinction in bipolar disorder patients run true over time? American Journal of Psychiatry 158 2001 1324 1326